In another instance, corrections of kirsten rat sarcoma viral oncogene homolog (KRAS) G12D mutation, observed in many cancers, showed reduced cell growth compared to the wild-type cells with KRAS G12D mutations (Lentsch et al., 2019). This evidence concerns the gene KRAS and cancer.